SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020539
Filing Date
2022-08-15
Accepted
2022-08-15 16:15:58
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20220630_10q.htm   iXBRL 10-Q 780247
2 EXHIBIT 10.7 ex_411168.htm EX-10.7 452240
3 EXHIBIT 31.1 ex_410772.htm EX-31.1 14456
4 EXHIBIT 31.2 ex_410773.htm EX-31.2 17330
5 EXHIBIT 32.1 ex_410774.htm EX-32.1 5710
6 EXHIBIT 32.2 ex_410775.htm EX-32.2 5807
  Complete submission text file 0001437749-22-020539.txt   4137191

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbla-20220630.xsd EX-101.SCH 36546
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20220630_cal.xml EX-101.CAL 23455
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20220630_def.xml EX-101.DEF 235841
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20220630_lab.xml EX-101.LAB 216292
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20220630_pre.xml EX-101.PRE 255044
47 EXTRACTED XBRL INSTANCE DOCUMENT pbla20220630_10q_htm.xml XML 422378
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 221165826
SIC: 2834 Pharmaceutical Preparations